Defining the role of imaging in choroidal nevi

Article

Optical coherence tomography is currently in high demand for the management of glaucoma patients, wet and dry macular degeneration, and a host of other ocular diseases.

Key Points

Choroidal nevi 101

Choroidal nevi occur in 5% to 10% of Caucasians, but are rare in dark-skinned races, according to Dr. Hessen, an instructor at Wilmer Eye Institute, Johns Hopkins University. Choroidal nevi are composed of a proliferation of spindle, polyhedral, dendritic, and balloon cells. Patients are frequently asymptomatic.

In a retrospective single-center case series of 120 consecutive eyes, researchers at Wilmer used the Zeiss Stratus OCT Model 3000 to scan 6 radial lines and complete retinal thickness analysis ( 2005;25:243-252). They analyzed the status of the retinal organization, particularly the photoreceptor layer over the nevus, and the reflectivity just posterior to the retinal pigment epithelium (RPE)/choriocapillaris and the nevus. They classified retinal edema as non-cystoid or cystoid, then compared this evaluation to a clinical evaluation in each patient.

Some findings from OCT included a more common incidence of diffuse cystoid overlying retinal edema than focal cystoid edema (8% versus 3%, respectively). For overlying retinal thickness, almost one-half were thickened (45%) compared with 32% that were of normal thickness.

"Of particular importance is that photo-receptor loss or attenuation was noted in 51% of cases. This may correspond vision loss or with visual field loss, particularly when the nevus is in or near the macula," she said.

Where OCT is more sensitive

Additional OCT findings included an increased thickness of RPE/choriocapillaris layer (68%). Optical qualities of the anterior surface were hyporeflective in 62% of nevi, and of those, 68% were pigmented and 18% were nonpigmented.

When OCT findings were compared with clinical examinations, researchers found that the OCT was more sensitive in detecting retinal edema, retinal fluid, RPE detachment, and retinal thinning.

"We were, however, better than the OCT at detecting drusen. I would say that there is a role for OCT in evaluating choroidal nevus, especially if you are not sure if there is overlying fluid present," Dr. Hessen said.

Age as a factor

The differential diagnosis for pigmented lesions includes congenital hypertrophy of the RPE, melanocytoma of the choroid, or small melanoma. For nonpigmented lesions, the differential diagnosis includes choroidal hemangioma, metastatic carcinoma, choroidal osteoma, posterior scleritis, or lymphoma.

Age may play some role in choroidal nevi formation, Dr. Hessen noted. A retrospective clinic-based study of 3,422 eyes at Wills Eye Institute reported no age-related correlation in symptoms, mean nevus base, intrinsic nevus pigmentation, related sub-retinal fluid, overlying orange pigment, RPE hyperplasia, or RPE atrophy. ( ogy. 2008;115-546-552.e2)

However, the study did find a statistical increase with age in multiple nevi per eye, mean nevus thickness, and overlying dru-sen. The investigators also concluded that the symptomatic nevi were more likely to be non-pigmented, beneath the fovea, and associated with subfoveal fluid.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
© 2025 MJH Life Sciences

All rights reserved.